Browse

You are looking at 81 - 90 of 14,382 items for

  • Refine by access: All content x
Clear All
Takanaga Shirai Institute of Health and Sport Sciences, University of Tsukuba, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan
Research Fellow of Japan Society for Promotion Science, Chiyoda-ku, Tokyo, Japan
Department of Human Sciences, Kanagawa University, Rokkakubashi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan

Search for other papers by Takanaga Shirai in
Google Scholar
PubMed
Close
,
Tomohiro Iwata Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan

Search for other papers by Tomohiro Iwata in
Google Scholar
PubMed
Close
,
Kazuki Uemichi Research Fellow of Japan Society for Promotion Science, Chiyoda-ku, Tokyo, Japan
Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan

Search for other papers by Kazuki Uemichi in
Google Scholar
PubMed
Close
,
Riku Tanimura Research Fellow of Japan Society for Promotion Science, Chiyoda-ku, Tokyo, Japan
Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan

Search for other papers by Riku Tanimura in
Google Scholar
PubMed
Close
,
Ryoto Iwai Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan

Search for other papers by Ryoto Iwai in
Google Scholar
PubMed
Close
, and
Tohru Takemasa Institute of Health and Sport Sciences, University of Tsukuba, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan

Search for other papers by Tohru Takemasa in
Google Scholar
PubMed
Close

Graphical abstract

Abstract

Calorie restriction (CR) is a widely recognized dietary approach with beneficial impacts on the entire body, including enhancements in oxidative metabolism and life span extension, while maintaining nutritional balance and calorie intake. However, CR leads to reductions in skeletal muscle and fat mass due to decreased food intake. Consequently, CR significantly modifies the metabolic profile of the entire body and its tissues. The observed benefits in skeletal muscle during CR may be attributed to CR-induced signaling mediators or significant changes in blood profiles associated with CR that regulate homeostasis maintenance. This study aimed to examine the mammalian target of rapamycin signaling and mitochondrial function of skeletal muscle from mice that undergone 8 weeks of CR and cells cultured in their serum to determine whether changes in blood secreted factors during CR affect skeletal muscle cells. C57BL6/J male mice were used. For 8 weeks, these were subjected to ad libitum (AL) or 40% CR. C2C12 myotubes were subsequently treated with media containing 10% mouse serum from AL or CR for 24 h. The results indicated that 8 weeks of CR decreased muscle mass and protein synthesis response compared with the AL group. Interestingly, myotubes conditioned with CR serum exhibited an elevation in the protein synthesis response compared with those treated with AL serum. Furthermore, mitochondrial function was enhanced in both CR mice and cells treated with CR serum. These findings suggest that while CR decreases the protein synthesis response, secretory factors present in the blood during CR can activate protein synthesis and promote mitochondrial function.

Restricted access
Emily J King Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
Central Clinical School, Monash University, Melbourne, Victoria, Australia

Search for other papers by Emily J King in
Google Scholar
PubMed
Close
,
Simon T Bond Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
Central Clinical School, Monash University, Melbourne, Victoria, Australia
Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, Australia

Search for other papers by Simon T Bond in
Google Scholar
PubMed
Close
,
Christine Yang Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia

Search for other papers by Christine Yang in
Google Scholar
PubMed
Close
,
Yingying Liu Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia

Search for other papers by Yingying Liu in
Google Scholar
PubMed
Close
,
Anna C Calkin Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
Central Clinical School, Monash University, Melbourne, Victoria, Australia
Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, Australia

Search for other papers by Anna C Calkin in
Google Scholar
PubMed
Close
,
Darren C Henstridge Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia

Search for other papers by Darren C Henstridge in
Google Scholar
PubMed
Close
, and
Brian G Drew Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
Central Clinical School, Monash University, Melbourne, Victoria, Australia
Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, Australia

Search for other papers by Brian G Drew in
Google Scholar
PubMed
Close

Type 2 diabetes mellitus (T2DM), a condition characterised by insulin resistance (IR) and skeletal muscle mitochondrial abnormalities, is a leading cause of death in developed societies. Much work has postulated that improving pathways linked to mitochondrial health, including autophagy, may be a potential avenue to prevent or treat T2DM. Given the recent data indicating a role for tripartite motif-containing 28 (TRIM28) in autophagy and mitochondrial pathways, we investigated whether muscle-specific deletion of TRIM28 might impact on obesity, glucose tolerance, and IR in mice. We studied two different muscle-specific (MCK-cre and ACTA1-cre-ERT2) TRIM28 knockout models, which were phenotyped during and after being fed a chow or high-fat diet (HFD). Whilst muscle-specific deletion of TRIM28 in both models demonstrated alterations in markers of mitochondrial activity and autophagy in skeletal muscle, we did not observe major impacts on the majority of metabolic measures in these mice. Specifically, we demonstrate that deletion of TRIM28 in skeletal muscle of mice during (MCK-cre) or post-development (ACTA1-cre-ERT2) does not prevent HFD-induced obesity or glucose intolerance. These findings are consistent with those reported previously in relation to autophagy and mitochondria in other cell types, and thus warrant further study into the biological role TRIM28 has in relation to mitochondrial function.

Restricted access
Leonardo Matta Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany
Institute for Diabetes and Cancer, Helmholtz Center Munich, Munich, Germany

Search for other papers by Leonardo Matta in
Google Scholar
PubMed
Close
,
Cinthia Breves Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Cinthia Breves in
Google Scholar
PubMed
Close
,
Luiz Fonte Boa Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Fonte Boa in
Google Scholar
PubMed
Close
,
Aina Eiras Domingos Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Aina Eiras Domingos in
Google Scholar
PubMed
Close
,
Caroline C Faria Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
UMR9019 CNRS, Université Paris-Saclay, Institut Gustave Roussy, Villejuif, France

Search for other papers by Caroline C Faria in
Google Scholar
PubMed
Close
,
Itanna Souza Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Itanna Souza in
Google Scholar
PubMed
Close
,
Niedson Correia Lima-Junior Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Niedson Correia Lima-Junior in
Google Scholar
PubMed
Close
,
Anna Paola Trindade Rocha Josué de Castro Institute of Nutrition, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Anna Paola Trindade Rocha in
Google Scholar
PubMed
Close
,
Bianca M Gregório Urogenital Research Unit, State University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Bianca M Gregório in
Google Scholar
PubMed
Close
,
Denise Pires Carvalho Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Denise Pires Carvalho in
Google Scholar
PubMed
Close
,
Andrea C F Ferreira Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Josué de Castro Institute of Nutrition, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Andrea C F Ferreira in
Google Scholar
PubMed
Close
,
José Hamilton Matheus Nascimento Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by José Hamilton Matheus Nascimento in
Google Scholar
PubMed
Close
,
Leonardo Maciel NUMPEX, Duque de Caxias Campus, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Leonardo Maciel in
Google Scholar
PubMed
Close
, and
Rodrigo S Fortunato Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Rodrigo S Fortunato in
Google Scholar
PubMed
Close

Estrogen deficiency is a well-known hallmark of menopause and is associated with oxidative stress and metabolic dysfunction. Quercetin (Q), a flavonoid found in fruits and vegetables, has demonstrated anti-inflammatory effects in experimental models of metabolic disorders. In this study, we aimed to investigate the effects of quercetin on retroperitoneal white adipose tissue (rWAT) redox homeostasis and systemic metabolic parameters in ovariectomized (OVX) rats. Female Wistar rats at 3 months old were divided into the following experimental groups: sham-operated treated with vehicle (DMSO 10% + PBS – 1 mL/kg); OVX (vehicle treated) and OVX-Q (25 mg/kg) – via oral gavage, daily for 5 weeks. Q did not prevent weight gain but improved glucose tolerance and blood cholesterol profile, and attenuated uterine atrophy in OVX rats. Furthermore, Q had a protective effect on rWAT, once the OVX-Q group presented lower oxidative stress levels, and reduced levels of the pro-inflammatory cytokine tumor necrosis factor alpha, compared to the OVX group. Q improved antioxidant enzyme activities such as superoxide dismutase and catalase and decreased reactive oxygen species production, in OVX-Q rats. It was followed by increased levels of total thiol content and lower lipid peroxidation. Moreover, Q reduced senescent-related genes p16INK4a and p19ARF expression which were higher in the OVX group. In conclusion, quercetin supplementation improved redox homeostasis and reduced senescence-related markers, and inflammation in rWAT, which was reflected in preserved systemic metabolic health parameters in OVX rats. These findings suggest that quercetin may have therapeutic potential for the management of metabolic disorders associated with menopause-induced estrogen deficiency.

Restricted access
Neil Tanday Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Neil Tanday in
Google Scholar
PubMed
Close
,
Aimee Coulter-Parkhill Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Aimee Coulter-Parkhill in
Google Scholar
PubMed
Close
,
R Charlotte Moffett Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Close
,
Karthick Suruli Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Karthick Suruli in
Google Scholar
PubMed
Close
,
Vaibhav Dubey Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Vaibhav Dubey in
Google Scholar
PubMed
Close
,
Peter R Flatt Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Close
, and
Nigel Irwin Diabetes Research Centre, Ulster University, Coleraine, Londonderry, Northern Ireland

Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Close

The present study examines differences in metabolic and pancreatic islet adaptative responses following streptozotocin (STZ) and hydrocortisone (HC) administration in male and female transgenic GluCreERT2/Rosa26-eYFP mice. Mice received five daily doses of STZ (50 mg/kg, i.p.) or 10 daily doses of HC (70 mg/kg, i.p.), with parameters assessed on day 11. STZ-induced hyperglycaemia was evident in both sexes, alongside impaired glucose tolerance and reduced insulin concentrations. HC also had similar metabolic effects in male and female mice resulting in classical increases of circulating insulin indicative of insulin resistance. Control male mice had larger pancreatic islets than females and displayed a greater reduction of islet and beta-cell area in response to STZ insult. In addition, female STZ mice had lower levels of beta-cell apoptosis than male counterparts. Following HC administration, female mouse islets contained a greater proportion of alpha cells when compared to males. All HC mice presented with relatively comparable increases in beta- and alpha-cell turnover rates, with female mice being slightly more susceptible to HC-induced beta-cell apoptosis. Interestingly, healthy control female mice had inherently increased alpha-to-beta-cell transdifferentiation rates, which was decreased by HC treatment. The number of glucagon-positive alpha cells altering their lineage to insulin-positive beta cells was increased in male, but not female, STZ mice. Taken together, although there was no obvious sex-specific alteration of metabolic profile in STZ or HC mice, subtle differences in pancreatic islet morphology emphasises the impact of sex hormones on islets and importance of taking care when interpreting observations between males and females.

Open access
James Cantley Division of Systems Medicine, School of Medicine, University of Dundee, UK

Search for other papers by James Cantley in
Google Scholar
PubMed
Close
,
Vincent Poitout Montreal Diabetes Research Center, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada
Department of Medicine, Université de Montréal, Montréal, QC, Canada

Search for other papers by Vincent Poitout in
Google Scholar
PubMed
Close
, and
Rebecca L Hull-Meichle Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA
Department of Medicine, University of Washington, Seattle, Washington, USA

Search for other papers by Rebecca L Hull-Meichle in
Google Scholar
PubMed
Close

The year 2023 marks 100 years since publication of the first report of a hyperglycemic factor in pancreatic extracts which C P Kimball and John R Murlin named glucagon (from GLUCose AGONist). Glucagon has a range of profound effects on metabolism including, but not limited to, stimulation of hepatic glucose production. Dysregulation of glucagon secretion is a key feature of both major forms of diabetes, leading to the concept that diabetes is a bihormonal disorder. Still, the work to fully understand the production and biological effects of glucagon has proceeded at a slower pace compared to that of insulin. A recent resurgence of interest in the islet alpha (α) cell, the predominant site of glucagon production, has been facilitated in part by technological innovations. This work has led to significant developments in the field, from defining how alpha cells develop and how glucagon secretion from pancreatic alpha cells is regulated to determining the role of glucagon in metabolic homeostasis and the progression of both major forms of diabetes. In addition, glucagon is considered to be a promising target for diabetes therapy, with many new potential applications arising from research in this field. This collection of reviews, led by Guest Editors James Cantley, Vincent Poitout and Rebecca Hull-Meichle, is intended to capture the field’s current understanding of glucagon and alpha cell biology, as well stimulate additional interest and research on this important hormone.

Free access
Marilyn B Renfree School of BioSciences, The University of Melbourne, Melbourne, Victoria, Australia

Search for other papers by Marilyn B Renfree in
Google Scholar
PubMed
Close
and
Geoff Shaw School of BioSciences, The University of Melbourne, Melbourne, Victoria, Australia

Search for other papers by Geoff Shaw in
Google Scholar
PubMed
Close

Since the discovery in 1968 that dihydrotestosterone (DHT) is a major mediator of androgen action, a convincing body of evidence has accumulated to indicate that the major pathway of DHT formation is the 5α-reduction of circulating testosterone in androgen target tissues. However, we now know that DHT can also be formed in peripheral tissues by the oxidation of 5α-androstane-3α,17β-diol (adiol). This pathway is responsible for the formation of the male phenotype. We discuss the serendipitous discovery in the tammar wallaby of an alternate pathway by which adiol is formed in the testes, secreted into plasma and converted in peripheral tissues to DHT. This alternate pathway is responsible for virilisation of the urogenital system in this species and is present in the testes at the onset of male puberty of all mammals studied so far. This is the first clear-cut function for steroid 5α-reductase 1 in males. Unexpectedly, the discovery of this pathway in this Australian marsupial has had a major impact in understanding the pathophysiology of aberrant virilisation in female newborns. Overactivity of the alternate pathway appears to explain virilisation in congenital adrenal hyperplasia CAH, in X-linked 46,XY disorders of sex development. It also appears to be important in polycystic ovarian syndrome (PCOS) since PCOS ovaries have enhanced the expression of genes and proteins of the alternate pathway. It is now clear that normal male development in marsupials, rodents and humans requires the action of both the classic and the alternate (backdoor) pathways.

Free access
Rocío Fuente Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland
Division of Pediatrics, University of Oviedo, Oviedo, Spain
Department of Pediatrics, Hospital Universitario Central, Oviedo, Spain

Search for other papers by Rocío Fuente in
Google Scholar
PubMed
Close
,
Eva-Maria Pastor-Arroyo Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Eva-Maria Pastor-Arroyo in
Google Scholar
PubMed
Close
,
Nicole Gehring Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Nicole Gehring in
Google Scholar
PubMed
Close
,
Patricia Oro Carbajosa Division of Pediatrics, University of Oviedo, Oviedo, Spain

Search for other papers by Patricia Oro Carbajosa in
Google Scholar
PubMed
Close
,
Laura Alonso-Durán Division of Pediatrics, University of Oviedo, Oviedo, Spain

Search for other papers by Laura Alonso-Durán in
Google Scholar
PubMed
Close
,
Ivan Zderic AO Research Institute Davos, AO Foundation, Clavadelerstrasse, Davos Platz, Switzerland

Search for other papers by Ivan Zderic in
Google Scholar
PubMed
Close
,
James Tapia-Dean Department of Pediatrics, Hospital Universitario Central, Oviedo, Spain

Search for other papers by James Tapia-Dean in
Google Scholar
PubMed
Close
,
Ahmad Kamal Hamid Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Ahmad Kamal Hamid in
Google Scholar
PubMed
Close
,
Carla Bettoni Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Carla Bettoni in
Google Scholar
PubMed
Close
,
Fernando Santos Division of Pediatrics, University of Oviedo, Oviedo, Spain
Department of Pediatrics, Hospital Universitario Central, Oviedo, Spain

Search for other papers by Fernando Santos in
Google Scholar
PubMed
Close
,
Carsten A Wagner Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Carsten A Wagner in
Google Scholar
PubMed
Close
, and
Isabel Rubio-Aliaga Institute of Physiology, University of Zurich, and National Center of Competence in Research NNCR Kidney, Zurich, CH, Switzerland

Search for other papers by Isabel Rubio-Aliaga in
Google Scholar
PubMed
Close

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone. X-linked hypophosphatemia (XLH) is the most prevalent inherited phosphate wasting disorder due to mutations in the PHEX gene, which cause elevated circulating FGF23 levels. Clinically, it is characterized by growth impairment and defective mineralization of bones and teeth. Treatment of XLH is challenging. Since 2018, neutralizing antibodies against FGF23 have dramatically improved the therapy of XLH patients, although not all patients fully respond to the treatment, and it is very costly. C-terminal fragments of FGF23 have recently emerged as blockers of intact FGF23 signaling. Here, we analyzed the effect on growth and bone of a short 26 residues long C-terminal FGF23 (cFGF23) fragment and two N-acetylated and C-amidated cFGF23 peptides using young XLH mice (Phex C733RMhda mice). Although no major changes in blood parameters were observed after 7 days of treatment with these peptides, bone length and growth plate structure improved. The modified peptides accelerated the growth rate probably by improving growth plate structure and dynamics. The processes of chondrocyte proliferation, death, hypertrophy, and the cartilaginous composition in the growth plate were partially improved in young treated XLH mice. In conclusion, these findings contribute to understand the role of FGF23 signaling in growth plate metabolism and show that this may occur despite continuous hypophosphatemia.

Restricted access
Yoo Kim Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Department of Nutritional Sciences, Oklahoma State University, Stillwater, Oklahoma, USA

Search for other papers by Yoo Kim in
Google Scholar
PubMed
Close
,
Junsik M Lee Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA

Search for other papers by Junsik M Lee in
Google Scholar
PubMed
Close
,
Youngah Han Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA

Search for other papers by Youngah Han in
Google Scholar
PubMed
Close
,
Rongya Tao Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Rongya Tao in
Google Scholar
PubMed
Close
,
Morris F White Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Morris F White in
Google Scholar
PubMed
Close
,
Renyan Liu Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Renyan Liu in
Google Scholar
PubMed
Close
, and
Sang Won Park Division of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Sang Won Park in
Google Scholar
PubMed
Close

Bromodomain-containing protein 7 (BRD7) has emerged as a player in the regulation of glucose homeostasis. Hepatic BRD7 levels are decreased in obese mice, and the reinstatement of hepatic BRD7 in obese mice has been shown to establish euglycemia and improve glucose homeostasis. Of note, the upregulation of hepatic BRD7 levels activates the AKT cascade in response to insulin without enhancing the sensitivity of the insulin receptor (InsR)–insulin receptor substrate (IRS) axis. In this report, we provide evidence for the existence of an alternative insulin signaling pathway that operates independently of IRS proteins and demonstrate the involvement of BRD7 in this pathway. To investigate the involvement of BRD7 as a downstream component of InsR, we utilized liver-specific InsR knockout mice. Additionally, we employed liver-specific IRS1/2 knockout mice to examine the requirement of IRS1/2 for the action of BRD7. Our investigation of glucose metabolism parameters and insulin signaling unveiled the significance of InsR activation in mediating BRD7’s effect on glucose homeostasis in the liver. Moreover, we identified an interaction between BRD7 and InsR. Notably, our findings indicate that IRS1/2 is not necessary for BRD7's regulation of glucose metabolism, particularly in the context of obesity. The upregulation of hepatic BRD7 significantly reduces blood glucose levels and restores glucose homeostasis in high-fat diet-challenged liver-specific IRS1/2 knockout mice. These findings highlight the presence of an alternative insulin signaling pathway that operates independently of IRS1/2 and offer novel insights into the mechanisms of a previously unknown insulin signaling in obesity.

Restricted access
S Khan Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by S Khan in
Google Scholar
PubMed
Close
,
D E W Livingstone Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
Centre for Discovery Brain Science, University of Edinburgh, Hugh Robson Building, Edinburgh, UK

Search for other papers by D E W Livingstone in
Google Scholar
PubMed
Close
,
A Zielinska College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Search for other papers by A Zielinska in
Google Scholar
PubMed
Close
,
C L Doig Department of Biosciences, School of Science & Technology, Nottingham Trent University, Nottingham, UK

Search for other papers by C L Doig in
Google Scholar
PubMed
Close
,
D F Cobice Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by D F Cobice in
Google Scholar
PubMed
Close
,
C L Esteves Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by C L Esteves in
Google Scholar
PubMed
Close
,
J T Y Man Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by J T Y Man in
Google Scholar
PubMed
Close
,
N Z M Homer Mass Spectrometry Core Laboratory, Edinburgh Clinical Research Facility, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by N Z M Homer in
Google Scholar
PubMed
Close
,
J R Seckl Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by J R Seckl in
Google Scholar
PubMed
Close
,
C L MacKay SIRCAMS, School of Chemistry, University of Edinburgh, Joseph Black Building, King's Buildings, Edinburgh, UK

Search for other papers by C L MacKay in
Google Scholar
PubMed
Close
,
S P Webster Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by S P Webster in
Google Scholar
PubMed
Close
,
G G Lavery Department of Biosciences, School of Science & Technology, Nottingham Trent University, Nottingham, UK

Search for other papers by G G Lavery in
Google Scholar
PubMed
Close
,
K E Chapman Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by K E Chapman in
Google Scholar
PubMed
Close
,
B R Walker Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
Clinical & Translational Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK

Search for other papers by B R Walker in
Google Scholar
PubMed
Close
, and
R Andrew Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
Mass Spectrometry Core Laboratory, Edinburgh Clinical Research Facility, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by R Andrew in
Google Scholar
PubMed
Close

11β-Hydroxysteroid dehydrogenase 1 (11βHSD1) is a drug target to attenuate adverse effects of chronic glucocorticoid excess. It catalyses intracellular regeneration of active glucocorticoids in tissues including brain, liver and adipose tissue (coupled to hexose-6-phosphate dehydrogenase, H6PDH). 11βHSD1 activity in individual tissues is thought to contribute significantly to glucocorticoid levels at those sites, but its local contribution vs glucocorticoid delivery via the circulation is unknown. Here, we hypothesised that hepatic 11βHSD1 would contribute significantly to the circulating pool. This was studied in mice with Cre-mediated disruption of Hsd11b1 in liver (Alac-Cre) vs adipose tissue (aP2-Cre) or whole-body disruption of H6pdh. Regeneration of [9,12,12-2H3]-cortisol (d3F) from [9,12,12-2H3]-cortisone (d3E), measuring 11βHSD1 reductase activity was assessed at steady state following infusion of [9,11,12,12-2H4]-cortisol (d4F) in male mice. Concentrations of steroids in plasma and amounts in liver, adipose tissue and brain were measured using mass spectrometry interfaced with matrix-assisted laser desorption ionisation or liquid chromatography. Amounts of d3F were higher in liver, compared with brain and adipose tissue. Rates of appearance of d3F were ~6-fold slower in H6pdh−/− mice, showing the importance for whole-body 11βHSD1 reductase activity. Disruption of liver 11βHSD1 reduced the amounts of d3F in liver (by ~36%), without changes elsewhere. In contrast disruption of 11βHSD1 in adipose tissue reduced rates of appearance of circulating d3F (by ~67%) and also reduced regenerated of d3F in liver and brain (both by ~30%). Thus, the contribution of hepatic 11βHSD1 to circulating glucocorticoid levels and amounts in other tissues is less than that of adipose tissue.

Open access
Daiana Araujo Santana-Oliveira Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Daiana Araujo Santana-Oliveira in
Google Scholar
PubMed
Close
,
Henrique Souza-Tavares Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Henrique Souza-Tavares in
Google Scholar
PubMed
Close
,
Aline Fernandes-da-Silva Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Aline Fernandes-da-Silva in
Google Scholar
PubMed
Close
,
Flavia Maria Silva-Veiga Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Flavia Maria Silva-Veiga in
Google Scholar
PubMed
Close
,
Gustavo Casimiro-Lopes Department of Gymnastics, Physical Education and Sports Institute, Laboratory of Exercise Pathophysiology (LAFE), Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Gustavo Casimiro-Lopes in
Google Scholar
PubMed
Close
,
Patricia Cristina Lisboa Laboratory of Endocrine Physiology, Biology Institute, Rio de Janeiro State University, Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Patricia Cristina Lisboa in
Google Scholar
PubMed
Close
,
Carlos Alberto Mandarim-de-Lacerda Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Carlos Alberto Mandarim-de-Lacerda in
Google Scholar
PubMed
Close
, and
Vanessa Souza-Mello Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil

Search for other papers by Vanessa Souza-Mello in
Google Scholar
PubMed
Close

Gut dysbiosis impairs nonshivering thermogenesis (NST) in obesity. The antiobesogenic effects of exercise training might involve the modulation of gut microbiota and its inflammatory signals to the brown adipose tissue (BAT). This study evaluated whether high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) prevent overweight through reduced gut-derived inflammatory signals to BAT in high-fat-fed mice. Sixty male C57BL/6 mice (3 months old) comprised six experimental groups: control (C) diet group, C diet + HIIT (C-HIIT) group, C diet + MICT (C-MICT) group, high-fat (HF) diet group, HF diet + HIIT (HF-HIIT) group, and HF diet + MICT (HF-MICT) group. The protocols lasted for 10 weeks. HIIT and MICT restored body mass, mitigated glucose intolerance, and prevented hyperinsulinemia in HF-trained groups. A chronic HF diet caused dysbiosis, but HIIT and MICT prevented gut dysbiosis and preserved tight junction (TJ) gene expression. HF-HIIT and HF-MICT groups exhibited a similar pattern of goblet cell distribution, agreeing with the decreased plasma lipopolysaccharide concentrations and interscapular BAT (iBAT) Lbp-Cd14-Tlr4 expression. The lowered Nlrp3 and Il1β in the HF-HITT and HF-MICT groups complied with iBAT thermogenic capacity maintenance. This study shows reliable evidence that HIIT and MICT prevented overweight by restoring the diversity of the gut microbiota phyla and TJ gene expression, thereby reducing inflammatory signals to brown adipocytes with preserved thermogenic capacity. Both exercise modalities prevented overweight, but HIIT rescued Zo-1 and Jam-a gene expression, exerting more potent anti-inflammatory effects than MICT (reduced LPS concentrations), providing a sustained increase in thermogenesis with 78% less distance traveled.

Restricted access